Cytochrome P4501B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer

被引:23
|
作者
Wen, Xia [1 ]
Walle, Thomas [1 ]
机构
[1] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA
关键词
esophageal carcinogenesis; benzo[a]pyrene; CYP1B1; methoxylated flavones;
D O I
10.1016/j.canlet.2006.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Esophageal cancer is common worldwide, with poor prognosis. Smoking, including exposure to polyaromatic hydrocarbons like benzo[a]pyrene (BaP), is a major risk factor. In human esophageal HET-1A cells, we found that time-dependent BaP-DNA binding was associated with upregulation of CYP1B1, but not CYP1A1, mRNA and protein. The dietary flavonoid 5,7-dimethoxyflavone significantly inhibited BaP-DNA binding and down-regulated BaP-induced CYP1B1 mRNA and protein. 3',4'-Dimethoxyflavone was an even more potent inhibitor of CYP1B1 expression, while resveratrol had no effect. Thus, dietary methoxylated flavones inhibited BaP-induced CYP1B1 transcription in a cell-specific manner and hold promise as chemopreventive agents in esophageal carcinogenesis. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [41] Modulation of human cytochrome P4501B1 expression by 2,4,3′,5′-tetramethoxystilbene
    Chun, YJ
    Lee, SK
    Kim, MY
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (12) : 1771 - 1776
  • [42] Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P4501B1 inhibitors
    Kim, S
    Ko, H
    Park, JE
    Jung, S
    Lee, SK
    Chun, YJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (01) : 160 - 164
  • [43] Coumarins are competitive inhibitors of cytochrome P4501B1, with equal potency for allelic variants
    Mammen, JS
    Kleiner, HE
    DiGiovanni, J
    Sutter, TR
    Strickland, PT
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (03): : 183 - 188
  • [44] Novel cytochrome P4501B1 (CYP1B1) gene mutations in Japanese patients with primary congenital glaucoma
    Mashima, Y
    Suzuki, Y
    Sergeev, Y
    Ohtake, Y
    Tanino, T
    Kimura, I
    Miyata, H
    Aihara, M
    Tanihara, H
    Inatani, M
    Azuma, N
    Iwata, T
    Araie, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (10) : 2211 - 2216
  • [45] Cytochrome P4501B1 gene mutations Japanese patients with primary congenital glaucoma
    Kakiuchi-Matsumoto, T
    Isashiki, Y
    Ohba, N
    Kimura, K
    Sonoda, S
    Unoki, K
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (03) : 345 - 350
  • [46] The role of cytochrome P4501B1 in dibenzo[a,l]lipyrene-induced carcinogenesis
    Luch, A
    Greim, H
    Buters, JTM
    Mahadevan, B
    Baird, WM
    Doehmer, J
    Seidel, A
    Glatt, H
    POLYCYCLIC AROMATIC COMPOUNDS, 2002, 22 (3-4) : 781 - 789
  • [47] Molecular characterization of human cytochrome P4501B1 (CYP1B1) gene in Italian PCG patients.
    Maninchedda, G
    Spinelli, P
    Fossarello, M
    Fattorini, M
    Serra, A
    Bonomi, L
    Pirastu, M
    Angius, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 380 - 380
  • [48] Regioselective 2-hydroxylation of 17β-estradiol by rat cytochrome P4501B1
    Rahman, Mostafizur
    Sutter, Carrie Hayes
    Emmert, Gary L.
    Sutter, Thomas R.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 216 (03) : 469 - 478
  • [49] Expression of cytochrome P4501b1 (Cyp1b1) during early murine development
    Stoilov, I
    Rezaie, T
    Jansson, I
    Schenkman, J
    Sarfarazi, M
    MOLECULAR VISION, 2004, 10 (74-75): : 629 - 636
  • [50] Inhibition of human cytochrome P4501B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin
    Takahashi, E
    Fujita, K
    Kamataki, T
    Arimoto-Kobayashi, S
    Okamoto, K
    Negishi, T
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 508 (1-2) : 147 - 156